第682号委员会意见摘要:微阵列与下一代测序技术:先进遗传学诊断工具在妇产科中的应用
该委员会意见指出,产前染色体微阵列分析推荐用于超声发现胎儿一处或多处主要结构异常且正在进行侵入性产前诊断的孕妇;全基因组或全外显子组测序在临床试验范围之外不推荐用于产前诊断的常规使用。
要点
- 产前染色体微阵列分析推荐用于超声发现胎儿一处或多处主要结构异常且接受侵入性产前诊断的孕妇。
- 全基因组或全外显子组测序在临床试验范围之外不推荐用于产前诊断的常规使用。
- 染色体微阵列分析可检测染色体非整倍体、染色体结构的大改变及传统方法无法检测的亚显微异常。
核心结论
- 产前染色体微阵列分析推荐用于超声发现胎儿一处或多处主要结构异常且正在进行侵入性产前诊断的孕妇。
- 全基因组或全外显子组测序在临床试验范围之外不推荐用于产前诊断的常规使用。
研究设计与样本
- 该文件为委员会意见摘要,未报告系统检索范围或样本量。
主要发现
- 染色体微阵列分析可检测染色体非整倍体、染色体结构的大改变以及传统方法无法检测的亚显微异常。
- 全基因组测序分析整个基因组,包括非编码区(内含子)和编码区(外显子),但因内含子通常临床相关性低,焦点转向分析编码区的外显子组测序。
- 外显子通常具有更高的临床相关性和对患者诊疗的适用性。
关键数值与推荐
- 产前染色体微阵列分析推荐用于超声发现胎儿一处或多处主要结构异常且正在进行侵入性产前诊断的孕妇。
- 全基因组或全外显子组测序在临床试验范围之外不推荐用于产前诊断的常规使用。
临床怎么用
- 对于超声发现胎儿一处或多处主要结构异常且正在进行侵入性产前诊断的孕妇,推荐产前染色体微阵列分析。
- 全基因组或全外显子组测序在临床试验范围之外不推荐用于产前诊断的常规使用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Genetic technology has advanced dramatically in the past few decades, and its applications and use in caring for and counseling pregnant women has been transformational in the realm of prenatal diagnosis. Two of the newer genetic technologies in the prenatal setting are chromosomal microarray and whole-exome sequencing. Chromosomal microarray analysis is a method of measuring gains and losses of DNA throughout the human genome. It can identify chromosomal aneuploidy and other large changes in the structure of chromosomes as well as submicroscopic abnormalities that are too small to be detected by traditional modalities. Prenatal chromosomal microarray analysis is recommended for a patient with a fetus with one or more major structural abnormalities identified on ultrasonographic examination and who is undergoing invasive prenatal diagnosis. Whole-genome sequencing analyzes the entire genome, including noncoding regions (introns) and coding regions (exons). However, because the introns are typically of little clinical relevance, there has been a focus instead on whole-exome sequencing, which examines the coding regions (exons) of the genome. The exons generally have greater clinical relevance and applicability to patient care. However, the routine use of whole-genome or whole-exome sequencing for prenatal diagnosis is not recommended outside of the context of clinical trials.
引用
- Committee Opinion No. 682 Summary: Microarrays and Next-Generation Sequencing Technology: The Use of Advanced Genetic Diagnostic Tools in Obstetrics and Gynecology. Obstet Gynecol. 2016. PMID: 27875471. doi:10.1097/AOG.0000000000001814
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。